blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3507298

EP3507298 - DETECTING HEPATOCELLULAR CARCINOMA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2024
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  28.07.2023
FormerGrant of patent is intended
Status updated on  15.03.2023
FormerExamination is in progress
Status updated on  24.12.2021
FormerRequest for examination was made
Status updated on  07.06.2019
FormerThe international publication has been made
Status updated on  10.03.2018
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): BE, SI		published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, MN 55905 / US
For all designated states
Exact Sciences Corporation
5505 Endeavor Lane
Madison, Wisconsin 53719 / US
[2023/35]
Former [2022/23]For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, MN 55905 / US
For all designated states
Exact Sciences Corporation
5505 Endeavor Lane
Madison, Wisconsin 53719 / US
Former [2019/28]For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, MN 55905 / US
For all designated states
Exact Sciences Development Company, LLC
441 Charmany Drive
Madison, Wisconsin 53719 / US
Inventor(s)01 / TAYLOR, William R.
c/o Mayo Foundation for Medical
Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
02 / AHLQUIST, David A.
c/o Mayo Foundation for Medical
Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
03 / MAHONEY, Douglas W.
c/o Mayo Foundation for Medical
Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
04 / KISIEL, John B.
c/o Mayo Foundation for Medical
Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
05 / YAB, Tracy C.
c/o Mayo Foundation for Medical
Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
06 / ALLAWI, Hatim T.
c/o Exact Sciences Corporation
441 Charmany Drive
Madison, Wisconsin 53719 / US
07 / GIAKOUMOPOULOS, Maria
c/o Exact Sciences Corporation
441 Charmany Drive
Madison, Wisconsin 53719 / US
08 / LIDGARD, Graham P.
c/o Exact Sciences Corporation
441 Charmany Drive
Madison, Wisconsin 53719 / US
 [2019/28]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[2023/35]
Former [2019/28]Algemeen Octrooi- en Merkenbureau B.V.
P.O. Box 645
5600 AP Eindhoven / NL
Application number, filing date17847642.001.09.2017
[2019/28]
WO2017US49915
Priority number, dateUS201662383165P02.09.2016         Original published format: US 201662383165 P
[2019/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018045322
Date:08.03.2018
Language:EN
[2018/10]
Type: A1 Application with search report 
No.:EP3507298
Date:10.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2018 takes the place of the publication of the European patent application.
[2019/28]
Type: B1 Patent specification 
No.:EP3507298
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)International search report - published on:US08.03.2018
(Supplementary) European search report - dispatched on:EP10.02.2021
ClassificationIPC:C12Q1/6886
[2020/47]
CPC:
C12Q1/6886 (EP,CN,KR,US); C12Q1/6827 (KR); C12Q2521/331 (KR);
C12Q2565/627 (KR); C12Q2600/154 (EP,CN,KR,US); C12Q2600/16 (CN,KR,US);
C12Q2600/166 (CN,KR,US) (-)
Former IPC [2019/28]C07H21/04, C12Q1/68, G06F19/00, G06F19/22
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/28]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ERKENNUNG EINES LEBERZELLKARZINOMS[2019/28]
English:DETECTING HEPATOCELLULAR CARCINOMA[2019/28]
French:DÉTECTION D'UN CARCINOME HÉPATOCELLULAIRE[2019/28]
Entry into regional phase01.03.2019National basic fee paid 
01.03.2019Search fee paid 
01.03.2019Designation fee(s) paid 
01.03.2019Examination fee paid 
Examination procedure01.03.2019Examination requested  [2019/28]
09.08.2021Amendment by applicant (claims and/or description)
23.12.2021Despatch of a communication from the examining division (Time limit: M04)
25.04.2022Reply to a communication from the examining division
16.03.2023Communication of intention to grant the patent
21.07.2023Fee for grant paid
21.07.2023Fee for publishing/printing paid
21.07.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23191397.1  / EP4293128
Opposition(s)03.06.2024No opposition filed within time limit [2024/32]
Fees paidRenewal fee
27.09.2019Renewal fee patent year 03
28.09.2020Renewal fee patent year 04
27.09.2021Renewal fee patent year 05
27.09.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
LU01.09.2023
BE30.09.2023
CH30.09.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
[2024/36]
Former [2024/34]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SK30.08.2023
SM30.08.2023
LU01.09.2023
CH30.09.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/28]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SK30.08.2023
SM30.08.2023
LU01.09.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/25]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SK30.08.2023
SM30.08.2023
LU01.09.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/23]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/22]AT30.08.2023
CZ30.08.2023
DK30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/20]AT30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/14]AT30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/10]AT30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/09]AT30.08.2023
FI30.08.2023
LT30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/08]LT30.08.2023
NO30.11.2023
GR01.12.2023
Documents cited:Search[A]US2011256538  (SU YING-HSIU [US], et al) [A] 2,7-9 * claims 1-4, 9 *;
 [I]CN104762301  (UNIV WUHAN) [I] 10 * claims 1-6 *;
 [A]EP2899274  (SYSMEX CORP [JP], et al) [A] 1-10* the whole document *;
 [XI]US2016090634  (KISIEL JOHN B [US], et al) [X] 1,4,5,10 * paragraph [0024]; example 2 * [I] 3,6;
 [X]  - BRADLEY W ANDERSON ET AL, "Aberrant Methylation During Gastric Carcinogenesis: Patterns of Acquisition Using Novel Methylated DNA Markers From Whole Methylome Discovery", GASTROENTEROLOGY, (20160401), vol. 150, no. 4, doi:https://doi.org/10.1016/S0016-5085(16)32909-2, pages S863 - S864, XP055737623 [X] 1,4,5 * the whole document *

DOI:   http://dx.doi.org/https://doi.org/10.1016/S0016-5085(16)32909-2
 [A]  - SOHACHI NANJO ET AL, "Identification of gastric cancer risk markers that are informative in individuals with past.infection", GASTRIC CANCER, SPRINGER-VERLAG, TO, (20120112), vol. 15, no. 4, doi:10.1007/S10120-011-0126-1, ISSN 1436-3305, pages 382 - 388, XP035128377 [A] 2,7-9 * table 1 *

DOI:   http://dx.doi.org/10.1007/s10120-011-0126-1
 [XYI]  - QIU XUEPING ET AL, "Hypermethylation ofACP1,BMP4, andTSPYL5in Hepatocellular Carcinoma and Their Potential Clinical Significance", DIGESTIVE DISEASES AND SCIENCES, SPRINGER NEW YORK LLC, US, vol. 61, no. 1, doi:10.1007/S10620-015-3878-3, ISSN 0163-2116, (20150919), pages 149 - 157, (20150919), XP035905801 [X] 1,4,5 * page 151, column r, paragraph l; figures 1, 3 * [Y] 7-9 [I] 2,3,6

DOI:   http://dx.doi.org/10.1007/s10620-015-3878-3
 [Y]  - WENQING HUANG ET AL, "Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis", GENETIC TESTING AND MOLECULAR BIOMARKERS, United States, (20150601), vol. 19, no. 6, doi:10.1089/gtmb.2014.0292, ISSN 1945-0265, pages 295 - 302, XP055737817 [Y] 7-9 * table 2 *

DOI:   http://dx.doi.org/10.1089/gtmb.2014.0292
 [I]  - JING SHEN ET AL, "Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas", BMC MEDICAL GENOMICS, (20150610), vol. 8, no. 1, doi:10.1186/s12920-015-0105-1, XP055770789 [I] 2,3,6 * figure 3 *

DOI:   http://dx.doi.org/10.1186/s12920-015-0105-1
 [A]  - TIAN-ZHOU ZHA ET AL, "Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma", TUMOR BIOLOGY, CH, (20120804), vol. 33, no. 6, doi:10.1007/s13277-012-0472-6, ISSN 1010-4283, pages 2125 - 2134, XP055771443 [A] 1-9 * figure 1; table 1 *

DOI:   http://dx.doi.org/10.1007/s13277-012-0472-6
 [A]  - TSOU JEFFREY A ET AL, "Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, (20071029), vol. 6, no. 1, ISSN 1476-4598, page 70, XP021036914 [A] 1-9 * table 2 *
International search[A]US2003143606  (OLEK ALEXANDER [DE], et al);
 [A]US2008039413  (MORRIS DAVID W [US], et al);
 [Y]US2011287968  (WEINHAUSEL ANDREAS [AT], et al);
 [A]US2014162894  (HATCHWELL ELI [GB], et al);
 [XY]US2014358448  (TAI KAYA [JP], et al);
 [Y]WO2016097120  (HOSPITAL CLÍNIC DE BARCELONA [ES], et al);
by applicantUS4683195
 US4683202
 US4965188
 US5011769
 US5124246
 US5288609
 US5338671
 WO9500669
 US5403711
 US5409818
 WO9515373
 US5494810
 US5508169
 US5624802
 US5639611
 US5660988
 WO9746705
 US5710264
 US5773258
 US5786146
 US5792614
 US5846717
 US5849481
 US5851770
 US5882867
 WO9928498
 US5914230
 US5958692
 US5965408
 US5985557
 US5994069
 US6001567
 US6013170
 WO0026401
 US6063573
 US6090543
 US6110684
 US6110677
 US6121001
 US6150097
 US6183960
 US6210884
 US6221583
 US6235502
 US6248229
 US6251594
 US6265171
 WO2005023091
 US6872816
 US2007202525
 US2009253142
 US7662594
 US2011256538
 US8361720
 US2016090634
 US20100946737
 US20100946745
 US20100946752
 US19390615486
 US19860614853
 US19970622490
 WO2004EP11715
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.